TrialLeukemia2016

Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS).

M Mossner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.